semaglutide injection fda approval Receives for Treatment of MASH Ozempic is first GLP-1 drug

If you hav ea new vial, pop the colored cap off and throw it away

20, 2025) The Partnership for Safe Medicines today released a new report that found suspicious, unauthorized, and illegal ingredients for popular diabetes and obesity injectables (commonly known as weight loss drugs) are flooding into the U.S

For example, a study on asiatic acid (AA) demonstrated that AA significantly inhibits oxidative stress, reduces cytokine and chemokine production, and decreases inflammatory cascade through inhibition of NLRP3 inflammasome and NF-B pathway, similar to mechanisms observed with other plant antioxidants such as curcumin and resveratrol in suppressing NF-B activation

Published work in this area has looked at receptor binding, signaling selectivity and metabolic endpoints in incretin-pathway models

The medical community first showed interest in the potential of GLP-1s in treating alcohol addiction when the drugs proved effective with obesity in 2014

GIP receptor co-activation is believed to potentiate insulin secretion, improve lipid metabolism, and enhance central appetite regulation through mechanisms complementary to GLP-1R signaling